1. Putting the pieces together: adding efficiency to your synbio workflow through automation. 2. Streamlining cell line development processes with automated antibody analytics.

Tuesday, February 6, 2024

12:00 PM – 1:00 PM EST

Room/Location: 104B

Sponsored By

Chris Saenz, MSc (he/him/his)

Beckman Coulter Life Sciences, California, United States
LE

Lori Euler, MS, BS (she/her/hers)

Beckman Coulter Life Sciences, Indiana, United States
Peter Braun (he/him/his)

Beckman Coulter GmbH, Nordrhein-Westfalen, Germany
Brian Murphy, MS, BS (he/him/his)

Beckman Coulter Life Sciences, Indiana, United States

Cell line development is still one of the rate-limiting steps in the bioprocessing end of bringing a new drug to market. As the increasing use of high-throughput and automation solutions in cell line development (CLD) has increased both the speed & sample output of these workflows, ensuring suitable automation friendly bio-analytics are in place is critical in preventing process bottlenecks. Here we describe the use of ValitaTiter & ValitaAggregation, simple, high-throughput & automation friendly plate-based antibody quantification & quality assays, and the benefit of automation in supporting the needs of high-throughput CLD workflows.